Language:
  
[Sign in] [Register]   

EIAab logo

Index > Protein center > SERPING1(Gene name) > Human
  • Add your favorite
  • SERPING1 (Gene name),
  • Plasma protease C1 inhibitor (Protein name ),  IC1_HUMAN from NCBI database.
  • top
  • Come back to page head.
  • |
  • General Annotation
  • |
  • Antigen Annotation
  • |
  • 3D
  • |
  • Predicted Eptitope
  • |
  • Vaild Sequence
  • |
  • Related Databases
  • |
  • Feedback
  • Gene name:
    SERPING1(C1IN;C1NH);
    Protein name:
    Plasma protease C1 inhibitor(C1 Inh;C1Inh);
    Alternative:
    C1-inhibiting factor;C1 esterase inhibitor;Serpin G1;
    Organism:
    Human (Homo sapiens). 
    General Annotation
    Sub Unit:
    Binds to E.coli stcE which allows localization of SERPING1 to cell membranes thus protecting the bacteria against complement-mediated lysis. Interacts with MASP1.
    Function:
    Activation of the C1 complex is under control of the C1-inhibitor. It forms a proteolytically inactive stoichiometric complex with the C1r or C1s proteases. May play a potentially crucial role in regulating important physiological pathways including complement activation, blood coagulation, fibrinolysis and the generation of kinins. Very efficient inhibitor of FXIIa. Inhibits chymotrypsin and kallikrein.
    Subcellular Location:
    Secreted
    Protein Attributes:
    Sequence length:
    500
    Sequence:
    50:
    MASRLTLLTL | LLLLLAGDRA | SSNPNATSSS | SQDPESLQDR | GEGKVATTVI | 
    100:
    SKMLFVEPIL | EVSSLPTTNS | TTNSATKITA | NTTDEPTTQP | TTEPTTQPTI | 
    150:
    QPTQPTTQLP | TDSPTQPTTG | SFCPGPVTLC | SDLESHSTEA | VLGDALVDFS | 
    200:
    LKLYHAFSAM | KKVETNMAFS | PFSIASLLTQ | VLLGAGENTK | TNLESILSYP | 
    250:
    KDFTCVHQAL | KGFTTKGVTS | VSQIFHSPDL | AIRDTFVNAS | RTLYSSSPRV | 
    300:
    LSNNSDANLE | LINTWVAKNT | NNKISRLLDS | LPSDTRLVLL | NAIYLSAKWK | 
    350:
    TTFDPKKTRM | EPFHFKNSVI | KVPMMNSKKY | PVAHFIDQTL | KAKVGQLQLS | 
    400:
    HNLSLVILVP | QNLKHRLEDM | EQALSPSVFK | AIMEKLEMSK | FQPTLLTLPR | 
    450:
    IKVTTSQDML | SIMEKLEFFD | FSYDLNLCGL | TEDPDLQVSA | MQHQTVLELT | 
    500:
    3D Structure:
    N/A
    Predicted Eptitope:
    Please Sign in.
    EIAab Sequence  Vaild Sequence:
    Please Sign in.
    Related Databases
    UniGene:
    SMR:
    MIM:
    KEGG:
    String:
    Pfam:
    Uniprot:
     
    FOR
    ELISA Kit for Human C1 Inh
    Cat.:
    E0235m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human C1 Inh
    Cat.:
    E0235r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human C1 Inh
    Cat.:
    E0235h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    ELISA Kit for Human C1 Inh
    MSDS:
    Please sign in first.
    CLIA Kit for Human C1 Inh
    Cat.:
    U0235h
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Range:
    Please sign in first.
    CLIA Kit for Human C1 Inh
    MSDS:
    Please sign in first.
    CLIA Kit for Human C1 Inh
    Cat.:
    U0235m
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    CLIA Kit for Human C1 Inh
    Cat.:
    U0235r
    Price:
    Please sign in first.
    MSDS:
    Please sign in first.
    Packing:
    96T
    Polyclonal Antibody for Human C1 Inh
    Cat.:
    P0235Rb-h
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human C1 Inh
    Cat.:
    P0235Rb-r
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Polyclonal Antibody for Human C1 Inh
    Polyclonal Antibody for Human C1 Inh
    Cat.:
    P0235Rb-m
    Price:
    Please sign in first.
    Packing:
    40ug/0.2ml
    Monoclonal Antibody for Human C1 Inh
    Monoclonal Antibody for Human C1 Inh
    Monoclonal Antibody for Human C1 Inh
    Monoclonal Antibody for Human C1 Inh
    Protein for Human C1 Inh
    Protein for Human C1 Inh
    Protein for Human C1 Inh
    Protein for Human C1 Inh

    R&D Technical Data
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Precision
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Recovery
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    Linearity
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    For more information, please refer to the manual,Or contact our technical support: tech@eiaab.com.
    References
    1. 1.
      "Isolation and analysis of a cDNA coding for human C1 inhibitor."
      Que B.G. , Petra P.H.
      Biochem. Biophys. Res. Commun.137:620-625(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)
    2. 2.
      "Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization."
      Bock S.C. , Skriver K. , Nielsen E. , Thoegersen H.-C. , Wiman B. , Donaldson V.H. , Eddy R.L. , Marrinan J. , Radziejewska E. , Huber R. , Shows T.B. , Magnusson S.
      Biochemistry25:4292-4301(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1);PARTIAL PROTEIN SEQUENCE;GLYCOSYLATION AT ASN-25; THR-48; SER-64; ASN-69; THR-71; ASN-81; THR-83; THR-88; THR-92; THR-96; ASN-238; ASN-253 AND ASN-352
    3. 3.
      "Genomic and cDNA cloning of the human C1 inhibitor. Intron-exon junctions and comparison with other serpins."
      Carter P.E. , Dunbar B. , Fothergill J.E.
      Eur. J. Biochem.173:163-169(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)
    4. 4.
      "Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements."
      Carter P.E. , Duponchel C. , Tosi M. , Fothergill J.E.
      Eur. J. Biochem.197:301-308(1991) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
    5. 5.
      "Production of recombinant human C1 inhibitor in milk of transgenic rabbits for potential use in enzyme replacement therapy for hereditary angioedema."
      Heus J. , Platenburg-Kootwijk E. , Meershoek E. , De Winter R. , Knijnenburg J. , Kupers L. , Habex H. , Renaers I. , Samuel C. , Bonnarens L. , Hoffman S. , Brouwer M. , Hack E. , Horbach D. , Timmermans M. , Nuijens J. , Pieper F.
      Submitted (2001-10) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]
      tissue: Foreskin.
    6. 6.
      "Complete sequencing and characterization of 21,243 full-length human cDNAs."
      Ota T. , Suzuki Y. , Nishikawa T. , Otsuki T. , Sugiyama T. , Irie R. , Wakamatsu A. , Hayashi K. , Sato H. , Nagai K. , Kimura K. , Makita H. , Sekine M. , Obayashi M. , Nishi T. , Shibahara T. , Tanaka T. , Ishii S. , more...
      Nat. Genet.36:40-45(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3)
      tissue: Heart.
      tissue: Liver.
      tissue: Ovary.
      tissue: Uterus.
    7. 7.
      "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
      Kalnine N. , Chen X. , Rolfs A. , Halleck A. , Hines L. , Eisenstein S. , Koundinya M. , Raphael J. , Moreira D. , Kelley T. , LaBaer J. , Lin Y. , Phelan M. , Farmer A.
      Submitted (2003-05) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANT MET-480
    8. 8.
      Totoki Y. , Toyoda A. , Takeda T. , Sakaki Y. , Tanaka A. , Yokoyama S. , Ohara O. , Nagase T. , Kikuno R.F.
      Submitted (2005-03) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANT MET-480
      tissue: Brain.
    9. 9.
      SeattleSNPs variation discovery resource
      Submitted (2005-01) to the EMBL/GenBank/DDBJ databases
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA];VARIANT MET-480
    10. 10.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    11. 11.
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]
    12. 12.
      "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
      The MGC Project Team
      Genome Res.14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1);VARIANT MET-480
      tissue: Brain.
    13. 13.
      "Molecular cloning of the cDNA coding for human C1 inhibitor."
      Rauth G. , Schumacher G. , Buckel P. , Mueller-Esterl W.
      Protein Seq. Data Anal.1:251-257(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 6-500 (ISOFORM 1)
    14. 14.
      "The functional integrity of the serpin domain of C1-inhibitor depends on the unique N-terminal domain, as revealed by a pathological mutant."
      Bos I.G.A. , Lubbers Y.T.P. , Roem D. , Abrahams J.P. , Hack C.E. , Eldering E.
      J. Biol. Chem.278:29463-29470(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 18-188;VARIANT HAE 84-ASP--THR-138 DEL
      tissue: Blood.
    15. 15.
      "Human C1 inhibitor: improved isolation and preliminary structural characterization."
      Harrison R.A.
      Biochemistry22:5001-5007(1983) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 23-62
    16. 16.
      "Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements."
      Stoppa-Lyonnet D. , Carter P.E. , Meo T. , Tosi M.
      Proc. Natl. Acad. Sci. U.S.A.87:1551-1555(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 33-228
    17. 17.
      "Molecular cloning of human C1 inhibitor: sequence homologies with alpha 1-antitrypsin and other members of the serpins superfamily."
      Tosi M. , Duponchel C. , Bourgarel P. , Colomb M. , Meo T.
      Gene42:265-272(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 213-500 (ISOFORM 1/2/3)
    18. 18.
      "Molecular weights and isoelectric points of sperm antigens relevant to autoimmune infertility in men."
      Pillai S. , Wright D. , Gupta A. , Zhou G. , Hull G. , Jiang H. , Zhang H.
      J. Urol.155:1928-1933(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 217-233
    19. 19.
      "Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11."
      Davis A.E. III , Whitehead A.S. , Harrison R.A. , Dauphinias A. , Bruns G.A. , Cicardi M. , Rosen F.S.
      Proc. Natl. Acad. Sci. U.S.A.83:3161-3165(1986) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 241-458 (ISOFORM 1/2/3);PARTIAL PROTEIN SEQUENCE
    20. 20.
      "Crucial residues in the carboxy-terminal end of C1 inhibitor revealed by pathogenic mutants impaired in secretion or function."
      Verpy E. , Couture-Tosi E. , Eldering E. , Lopez-Trascasa M. , Spath P. , Meo T. , Tosi M.
      J. Clin. Invest.95:350-359(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 418-500;VARIANTS HAE MET-473; ARG-481; PRO-481; ARG-489 AND SER-498
    21. 21.
      "Chymotrypsin inhibitory activity of normal C1-inhibitor and a P1 Arg to His mutant: evidence for the presence of overlapping reactive centers."
      Aulak K.S. , Davis A.E. III , Donaldson V.H. , Harrison R.A.
      Protein Sci.2:727-732(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: PROTEIN SEQUENCE OF 464-481;FUNCTION;REACTIVE SITE FOR CHYMOTRYPSIN
      tissue: Plasma.
    22. 22.
      "Proteolytic activities of two types of mannose-binding lectin-associated serine protease."
      Matsushita M. , Thiel S. , Jensenius J.C. , Terai I. , Fujita T.
      J. Immunol.165:2637-2642(2000) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH MASP1
    23. 23.
      "StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor."
      Lathem W.W. , Grys T.E. , Witowski S.E. , Torres A.G. , Kaper J.B. , Tarr P.I. , Welch R.A.
      Mol. Microbiol.45:277-288(2002) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH E.COLI STCE;PROTEOLYTIC PROCESSING BY E.COLI STCE
    24. 24.
      "Identification and quantification of N-linked glycoproteins using hydrazide chemistry, stable isotope labeling and mass spectrometry."
      Zhang H. , Li X.-J. , Martin D.B. , Aebersold R.
      Nat. Biotechnol.21:660-666(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-253
    25. 25.
      "Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7."
      Lathem W.W. , Bergsbaken T. , Welch R.A.
      J. Exp. Med.199:1077-1087(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: INTERACTION WITH E.COLI STCE;PROTEOLYTIC PROCESSING BY E.COLI STCE
    26. 26.
      "Screening for N-glycosylated proteins by liquid chromatography mass spectrometry."
      Bunkenborg J. , Pilch B.J. , Podtelejnikov A.V. , Wisniewski J.R.
      Proteomics4:454-465(2004) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-25; ASN-238; ASN-253 AND ASN-352
      tissue: Plasma.
    27. 27.
      "N-linked glycosylation at Asn3 and the positively charged residues within the amino-terminal domain of the c1 inhibitor are required for interaction of the C1 Inhibitor with Salmonella enterica serovar typhimurium lipopolysaccharide and lipid A."
      Liu D. , Cramer C.C. , Scafidi J. , Davis A.E. III
      Infect. Immun.73:4478-4487(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-25
    28. 28.
      "Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry."
      Liu T. , Qian W.-J. , Gritsenko M.A. , Camp D.G. II , Monroe M.E. , Moore R.J. , Smith R.D.
      J. Proteome Res.4:2070-2080(2005) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-25; ASN-69; ASN-238; ASN-253 AND ASN-352
      tissue: Plasma.
    29. 29.
      "Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry."
      Chen R. , Jiang X. , Sun D. , Han G. , Wang F. , Ye M. , Wang L. , Zou H.
      J. Proteome Res.8:651-661(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-69; ASN-81; ASN-238; ASN-253 AND ASN-352
      tissue: Liver.
    30. 30.
      "A strategy for precise and large scale identification of core fucosylated glycoproteins."
      Jia W. , Lu Z. , Fu Y. , Wang H.P. , Wang L.H. , Chi H. , Yuan Z.F. , Zheng Z.B. , Song L.N. , Han H.H. , Liang Y.M. , Wang J.L. , Cai Y. , Zhang Y.K. , Deng Y.L. , Ying W.T. , He S.M. , Qian X.H.
      Mol. Cell. Proteomics8:913-923(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-238; ASN-253 AND ASN-352
    31. 31.
      "Enrichment of glycopeptides for glycan structure and attachment site identification."
      Nilsson J. , Rueetschi U. , Halim A. , Hesse C. , Carlsohn E. , Brinkmalm G. , Larson G.
      Nat. Methods6:809-811(2009) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-352;STRUCTURE OF CARBOHYDRATES
      tissue: Cerebrospinal fluid.
    32. 32.
      "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD."
      Halim A. , Nilsson J. , Ruetschi U. , Hesse C. , Larson G.
      Mol. Cell. Proteomics0:0-0(2011) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT ASN-25; THR-47 AND THR-48;STRUCTURE OF CARBOHYDRATES;IDENTIFICATION BY MASS SPECTROMETRY
    33. 33.
      "LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins."
      Halim A. , Ruetschi U. , Larson G. , Nilsson J.
      J. Proteome Res.12:573-584(2013) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: GLYCOSYLATION AT THR-47 AND THR-48;IDENTIFICATION BY MASS SPECTROMETRY
    34. 34.
      "C1 inhibitor serpin domain structure reveals the likely mechanism of heparin potentiation and conformational disease."
      Beinrohr L. , Harmat V. , Dobo J. , Loerincz Z. , Gal P. , Zavodszky P.
      J. Biol. Chem.282:21100-21109(2007) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 119-500;DISULFIDE BONDS;GLYCOSYLATION AT ASN-238
    35. 35.
      "What do dysfunctional serpins tell us about molecular mobility and disease?"
      Stein P.E. , Carrell R.W.
      Nat. Struct. Biol.2:96-113(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: REVIEW ON VARIANTS
    36. 36.
      "Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444-->His) mutation."
      Aulak K.S. , Pemberton P.A. , Rosen F.S. , Carrell R.W. , Lachmann P.J. , Harrison R.A.
      Biochem. J.253:615-618(1988) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE HIS-466
    37. 37.
      "Identification of a new P1 residue mutation (444Arg-->Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma."
      Aulak K.S. , Cicardi M. , Harrison R.A.
      FEBS Lett.266:13-16(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE SER-466
    38. 38.
      "Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene."
      Levy N.J. , Ramesh N. , Cicardi M. , Harrison R.A. , Davis A.E. III
      Proc. Natl. Acad. Sci. U.S.A.87:265-268(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE THR-458
    39. 39.
      "Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site."
      Parad R.B. , Kramer J. , Strunk R.C. , Rosen F.S. , Davis A.E. III
      Proc. Natl. Acad. Sci. U.S.A.87:6786-6790(1990) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE LYS-273 DEL
    40. 40.
      "Identification of type II hereditary angio-oedema (HAE) mutations."
      Siddique Z.M. , McPhaden A.R. , Whaley K.
      Clin. Exp. Immunol.86:11-12(1991)
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE GLU-456 AND VAL-458
    41. 41.
      "A dysfunctional C1 inhibitor protein with a new reactive center mutation (Arg-444-->Leu)."
      Frange D. , Aulak K.S. , Cicardi M. , Harrison R.A. , Davis A.E. III
      FEBS Lett.301:34-36(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE LEU-466
    42. 42.
      "C1 inhibitor hinge region mutations produce dysfunction by different mechanisms."
      Davis A.E. III , Aulak K. , Parad R.B. , Stecklein H.P. , Eldering E. , Hack C.E. , Kramer J. , Strunk R.C. , Bissler J. , Rosen F.S.
      Nat. Genet.1:354-358(1992) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE GLU-454 AND THR-458
    43. 43.
      "Mutations in the C1 inhibitor gene that result in hereditary angioneurotic edema."
      Davis A.E. III , Bissler J.J. , Cicardi M.
      Behring Inst. Mitt.93:313-320(1993) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE ARG-429
    44. 44.
      "Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein."
      Zahedi R. , Bissler J.J. , Davis A.E. III , Andreadis C. , Wisnieski J.J.
      J. Clin. Invest.95:1299-1305(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE VAL-465
    45. 45.
      "A mutation unique in serine protease inhibitors (serpins) identified in a family with type II hereditary angioneurotic edema."
      Ocejo-Vinyals J.G. , Leyva-Cobian F. , Fernandez-Luna J.L.
      Mol. Med.1:700-705(1995) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE PRO-467
    46. 46.
      "Exhaustive mutation scanning by fluorescence-assisted mismatch analysis discloses new genotype-phenotype correlations in angiodema."
      Verpy E. , Biasotto M. , Brai M. , Misiano G. , Meo T. , Tosi M.
      Am. J. Hum. Genet.59:308-319(1996) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE
    47. 47.
      "Mutation screening of the C1 inhibitor gene among Hungarian patients with hereditary angioedema."
      Kalmar L. , Bors A. , Farkas H. , Vas S. , Fandl B. , Varga L. , Fuest G. , Tordai A.
      Hum. Mutat.22:498-498(2003) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE TYR-130; PRO-394; VAL-408; CYS-466; GLU-473; GLU-493 AND ARG-498
    48. 48.
      "Normal C1 inhibitor mRNA expression level in type I hereditary angioedema patients: newly found C1 inhibitor gene mutations."
      Kang H.-R. , Yim E.-Y. , Oh S.-Y. , Chang Y.-S. , Kim Y.-K. , Cho S.-H. , Min K.-U. , Kim Y.-Y.
      Allergy61:260-264(2006) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANT HAE ARG-345;VARIANTS ALA-56 AND MET-480
    49. 49.
      "Mutational spectrum and geno-phenotype correlation in Chinese families with Hereditary Angioedema."
      Xu Y.Y. , Zhi Y.X. , Yin J. , Wang L.L. , Wen L.P. , Gu J.Q. , Guan K. , Craig T. , Zhang H.Y.
      Allergy67:1430-1436(2012) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE ALA-118; CYS-154; PHE-170; ARG-184; PRO-230; LYS-232; ASN-272 DEL; ARG-299; GLN-430; THR-441; PRO-447; SER-466; CYS-466; LEU-466; GLY-473 AND GLY-497;VARIANTS ALA-56 AND MET-480
    50. 50.
      "Mutational spectrum of the c1 inhibitor gene in a cohort of Italian patients with hereditary angioedema: description of nine novel mutations."
      Bafunno V. , Bova M. , Loffredo S. , Divella C. , Petraroli A. , Marone G. , Montinaro V. , Margaglione M. , Triggiani M.
      Ann. Hum. Genet.78:73-82(2014) [PubMed] [Europe PMC] [Abstract]
      [15/1/25 17:38] Upload to ab completed in less than a minute: 1 file transferred (13.4 Kb/s) Cited for: VARIANTS HAE ARG-11; ARG-265; VAL-274; THR-458; CYS-466; HIS-466; ARG-493 AND GLU-493
    Product Feedback Wall
    Hot Genes
    Atf2 ASPRO ACE ALCAM C19orf80 Trap1a Gdf5
    Top Searches
    Ubiquitin-protein ligase metalloproteinase Ubiquitin ELISA Tumor necrosis Alpha Asprosin TRAP1A
    Why choose EIAAB
    Our products have been quoted by many publications in famous journals such as Cell; Cell Metabolism; Hepatology; Biomaterials.more
    Further Information
    About us Protein center Bank account Distributors Terms & Conditions Career eiaab.com.cn

    Copyright & copy www.eiaab.com2006-2016 All Rights Reserved    EIAab         Email:eiaab@eiaab.com

    鄂ICP备10015095号-1

    鄂公网安备 42018502005535号

    Twitter